Interleukin-18 (IL-18) Inhibitors -Pipeline Insights, 2017 [Report Updated: 30-05-2017]

Published by Delve Insight: 30 May 2017 | 85587

Sorry, this report is no longer available.

We may have other suitable reports available - try Searching for Interleukin-18
or contact our sales team for personal assistance: phone +44 (0) 1305 753769 or email office@sectorpublishing.com.

Introduction

DelveInsight’s, “Interleukin-18 (IL-18) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Interleukin-18 (IL-18) Inhibitors. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Interleukin-18 (IL-18) Inhibitors. DelveInsight’s Report also assesses the Interleukin-18 (IL-18) Inhibitors therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope

• The report provides competitive pipeline landscape of Interleukin-18 (IL-18) Inhibitors

• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information

• Coverage of the Interleukin-18 (IL-18) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type

• The report reviews key players involved in the therapeutics development for Interleukin-18 (IL-18) Inhibitors and also provide company profiling

• The report also gives the information of dormant and discontinued pipeline projects

• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages

• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Delivery Time 48-72 Hours

Table of Contents
for Interleukin-18 (IL-18) Inhibitors -Pipeline Insights, 2017 [Report Updated: 30-05-2017]

List Of Tables
in Interleukin-18 (IL-18) Inhibitors -Pipeline Insights, 2017 [Report Updated: 30-05-2017]

• Number of Products under Development for Interleukin-18 (IL-18) Inhibitors by Therapy Area, 2017

• Number of Products under Development for Interleukin-18 (IL-18) Inhibitors, 2017

• Number of Products under Development by Companies

• Comparative Analysis by Filed and Phase III Products, 2017

• Comparative Analysis Phase II Products, 2017

• Comparative Analysis Phase I and IND Filed Products, 2017

• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2017

• Drug Candidates Profiles

• Interleukin-18 (IL-18) Inhibitors Assessment by Monotherapy Products

• Interleukin-18 (IL-18) Inhibitors Assessment by Combination Products

• Interleukin-18 (IL-18) Inhibitors Assessment by Route of Administration

• Interleukin-18 (IL-18) Inhibitors Assessment by Stage and Route of Administration

• Interleukin-18 (IL-18) Inhibitors Assessment by Molecule Type

• Interleukin-18 (IL-18) Inhibitors Assessment by Stage and Molecule Type

• Interleukin-18 (IL-18) Inhibitors Therapeutics – Discontinued Products

• Interleukin-18 (IL-18) Inhibitors Therapeutics – Dormant Products

• Products under Development by Companies, 2017

List Of Figures, Charts and Diagrams
in Interleukin-18 (IL-18) Inhibitors -Pipeline Insights, 2017 [Report Updated: 30-05-2017]

• Number of Products under Development for Interleukin-18 (IL-18) Inhibitors by Therapy Area, 2017

• Number of Products under Development for Interleukin-18 (IL-18) Inhibitors, 2017

• Filed and Phase III Products, 2017

• Phase II Products, 2017

• Phase I and IND Filed Products, 2017

• Discovery and Pre-Clinical Stage Products, 2017

• Interleukin-18 (IL-18) Inhibitors Assessment by Monotherapy Products

• Interleukin-18 (IL-18) Inhibitors Assessment by Combination Products

• Interleukin-18 (IL-18) Inhibitors Assessment by Route of Administration

• Interleukin-18 (IL-18) Inhibitors Assessment by Stage and Route of Administration

• Interleukin-18 (IL-18) Inhibitors Assessment by Molecule Type

• Interleukin-18 (IL-18) Inhibitors Assessment by Stage and Molecule Type

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

85587 | DIMR2017403

Number of Pages

60

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2016
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11....
21 Dec 2016 by Global Markets Direct USD $3,500 More Info
Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) - Pipeline Review, H2 2016
Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) - Pipeline Review, H2 2016SummaryGlobal Mark...
14 Dec 2016 by Global Markets Direct USD $3,500 More Info
Interleukin Genetics, Inc. (ILIU) - Medical Equipment - Deals and Alliances Profile
SummaryInterleukin Genetics Inc (Interleukin) is a molecular diagnostics company which develops and ...
14 Nov 2016 by Global Data USD $250 More Info
Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H2 2016
Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H2 2016SummaryGlobal M...
09 Nov 2016 by Global Markets Direct USD $3,500 More Info
Interleukin Genetics, Inc. (ILIU) - Medical Equipment - Deals and Alliances Profile
SummaryInterleukin Genetics, Inc. (Interleukin) is a molecular diagnostics company which develops an...
21 Jul 2016 by Global Data USD $250 More Info
Interleukin Genetics, Inc. (ILIU) - Financial and Strategic SWOT Analysis Review
Interleukin Genetics, Inc. (ILIU) - Financial and Strategic SWOT Analysis Review provides you an in-...
24 May 2016 by Global Data USD $125 More Info
Interleukin Genetics, Inc. (ILIU) - Medical Equipment - Deals and Alliances Profile
SummaryInterleukin Genetics, Inc. (Interleukin) is a molecular diagnostics company. It develops and ...
02 May 2016 by Global Data USD $250 More Info
CEL-SCI Corporation (formerly Interleukin-2, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
SummaryMarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments r...
15 Apr 2016 by Marketline USD $350 More Info
Interleukin Genetics, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and In...
10 Mar 2016 by Marketline USD $350 More Info
Interleukin Genetics, Inc. (ILIU) - Medical Equipment - Deals and Alliances Profile
SummaryInterleukin Genetics, Inc. (Interleukin) is a molecular diagnostics company. It develops and ...
24 Feb 2016 by Global Data USD $250 More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data